Helicobacter pylori assimilates various steroids as membrane lipid components, but it can also survive in the absence of steroids. It thus remains to be clarified as to why the organism relies on steroid physiologically. In this study, we have found that phosphatidylcholine carrying a linoleic acid molecule or arachidonic acid molecule has the potential to kill steroid-free H. pylori. The bactericidal action of phosphatidylcholines against H. pylori was due to the lytic activity of the phosphatidylcholines themselves and not due to the lytic activity of the unsaturated fatty acids or lyso-phosphatidylcholine resulting from the hydrolysis of the phosphatidylcholines. In contrast to the steroid-free H. pylori, the organism that absorbed and glucosylated free cholesterol was unaffected by the bactericidal action of the phosphatidylcholines. Similarly, H. pylori that absorbed estrone without glucosylating it also resisted the bactericidal action of the phosphatidylcholines. The steroids absorbed by H. pylori existed in both the outer and inner membranes, while the glucosyl-steroids produced via the steroid absorption were localized in the outer membrane rather than in the inner membrane. These results indicate that H. pylori absorbs the steroids to reinforce the membrane lipid barrier and thereby expresses resistance to the bacteriolytic action of hydrophobic compounds such as phosphatidylcholine.
Introduction
Helicobacter pylori is a pathogen responsible for chronic gastritis and peptic ulcers in humans (Marshall & Warren, 1983; Wyatt & Dixon, 1988; Graham, 1991) . This bacterium is a unique bacterial species that aggressively absorbs and retains exogenous steroid in the membranes. A recent study has demonstrated that H. pylori extracts free cholesterol (FC), a typical steroid compound, from a lipid raft in the gastric epithelial cell membrane and assimilates the FC as membrane lipid components via the glucosylation of its steroid . In a previous study, we identified the following three types of glucosylated FC (cholesteryl glucosides or CGs) in the membrane lipid compositions of the organisms (Hirai et al., 1995) : cholesteryl-a-D-glucopyranoside (CGL), cholesteryl-6-O-tetradecanoyl-a-D-glucopyranoside (CAG), and cholesteryl-6-O-phosphatidyl-a-D-glucopyranoside (CPG). One of the enzymes involved in the CG synthesis has been identified with cholesterol a-glucosyltransferase, encoded by the HP0421 gene in H. pylori (Lebrun et al., 2006) . The HP0421 catalyzes the synthesis of CGL by attaching a glucose molecule to a 3b-OH of the cholesterol via an a-glucosidic linkage. The transferases that attach a fatty acid or a phosphatidyl group to the CGL molecule have still not been identified in the organism. More recently, we have demonstrated that H. pylori selectively absorbs 3b-OH and 3-OH steroid hormones into the membranes and utilizes only 3b-OH steroid hormones as the materials for glucosylation (Hosoda et al., 2009) . However, we have empirically shown that H. pylori satisfactorily divides and multiplies in vitro even when cultured in the absence of steroids. In brief, H. pylori can apparently thrive and survive without relying on steroids. Our next task, therefore, is to clarify why H. pylori requires steroid physiologically.
Phosphatidylcholine, the most prevalent phospholipid in mammals, is much higher in concentration than FC in the blood plasma of humans; phosphatidylcholine exists at a concentration of approximately 144 mg dL À1 , whereas FC exists at a concentration of approximately 60 mg dL À1 (Nakamura, 1997) . In addition, only very few bacterial species synthesize phosphatidylcholine (Randle et al., 1969) . The fundamental chemical structure of phosphatidylcholine is 1,2-diacyl-sn-glycero-3-phosphocholine (Nakamura, 1997) . In general, the carbon 1 position in the glycerol backbone of phosphatidylcholine carries a saturated fatty acid such as palmitic acid (C 16:0 ) or stearic acid (C 18:0 ), whereas the carbon 2 position in the glycerol backbone of phosphatidylcholine carries an unsaturated fatty acid such as oleic acid (C 18:1 ), linoleic acid (C 18:2 ), or arachidonic acid (C 20:4 ). Lyso-phosphatidylcholine (LPC) is a monoacyl-type phosphatidylcholine and generally lacks an unsaturated fatty acid at the carbon 2 position in the glycerol backbone.
A number of investigations have demonstrated that unsaturated fatty acids and LPCs have the potential to kill various microorganisms, including H. pylori (Wyss et al., 1945; Nieman, 1954; Kabara et al., 1972; Conley & Kabara, 1973; Kanai & Kondo, 1979; Kanetsuna, 1985; Kondo & Kanai, 1985; Knapp & Melly, 1986; Constance et al., 1992; Thompson et al., 1994; Bruyn et al., 1996; Steel et al., 2002) . Thus, these individual lipophilic compounds constituting phosphatidylcholine act as antimicrobial agents against the microorganisms. It remains unclear, however, whether the phosphatidylcholine itself confers an antimicrobial action against the microorganisms. A previous study by others has shown that the concentration of phosphatidylcholine is 124.8 AE 62.6 mM in gastric juice from eight healthy volunteers (Berstad et al., 1992) . We know that H. pylori colonizes the human gastric epithelium. Thus, the above study indicates that H. pylori is surrounded by phosphatidylcholine in vivo. If phosphatidylcholine affects the survival of H. pylori that has failed to assimilate exogenous steroids such as FC or steroid hormones, it may explain the importance of steroid absorption in the organism. In this study, we, therefore, investigated the antibacterial activities of phosphatidylcholine against H. pylori with or without absorbed steroids.
Materials and methods

Bacterial strains and culture
Three strains of H. pylori (NCTC 11638, ATCC 43504, and a clinical isolate, A-19) were grown in a pleuropneumonialike organisms (PPLO) broth (Difco Laboratories, Detroit, MI) with or without 2,6-di-O-methyl-b-cyclodextrin (dMbCD; Sigma-Aldrich Inc., St. Louis, MO) and cultured with shaking in an atmosphere of 5% O 2 , 10% CO 2 , and 85% N 2 at 37 1C (Concept Plus; Ruskinn Technology, Leeds, UK). An appropriately sized colony of organisms grown on an agar plate was transferred into a broth and cultured for 24 h. The bacterial cell suspension (200 mL) grown in the broth was inoculated into a fresh medium (10 mL) and cultured for 24 h. The above subculture was repeated for three generations, and thereby, a preculture bacterial cell suspension was obtained.
Acclimatization of H. pylori to dMbCD-free PPLO dMbCD supports the growth of H. pylori (Marchini et al., 1995) and is widely used as a standard component of serumfree cultures for organisms at concentrations of 0.1-0.2%. Yet, to succeed with our experiments, we needed to obtain H. pylori cultures in a medium without dMbCD. To fulfil this condition, we established a method for growing the H. pylori in a dMbCD-free medium. First, organisms grown on a 0.2% dMbCD-PPLO agar plate were cultured in a liquid solution with 0.004% dMbCD-PPLO broth and acclimatized to a medium containing a low concentration of dMbCD by repeating the culture for more than three generations under microaerobic conditions. Next, organisms grown in a 0.004% dMbCD-PPLO broth were inoculated in a PPLO broth without dMbCD, and the cultures were repeated for more than three generations under microaerobic conditions. Finally, organisms grown in dMbCD-free PPLO broth were dispensed onto a PPLO agar plate without dMbCD and acclimatized.
Specimens
The following phosphatidylcholines (PCs), LPC, and fatty acids were investigated (see Fig. 1a ): 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (PC-1) and 2-oleoyl-1-palmitoylsn-glycero-3-phosphocholine (PC-2), from Nof Co. (Tokyo, Japan), 2-linoleoyl-1-palmitoyl-sn-3-phosphocholine (PC-3), 2-arachidonoyl-1-palmitoyl-sn-3-phosphocholine (PC-4), 1-palmitoyl-sn-glycero-3-phosphocholine (LPC), linoleic acid (C 18:2 ), and arachidonic acid (C 20:4 ), from Sigma-Aldrich Inc., and palmitic acid (C 16:0 ), from Nof Co. Each specimen was dissolved in ethanol and stored at À 80 1C in the dark until use in the experiments. Cholesterol (FC), from Wako Pure Chemical Industries Ltd (Tokyo, Japan), was also dissolved in ethanol and stored at room temperature in the dark. Estrone (E1) and testosterone (TS), from Wako Pure Chemical Industries Ltd, were dissolved in dimethyl sulfoxide (DMSO) and stored at room temperature in the dark. The 2 mL mL À1 concentration of the ethanol and the 0.1% concentration of the DMSO used in this study did not affect the viability of the H. pylori.
Proliferation assay
The preculture bacterial cell suspension (200 mL) was inoculated into a broth (10 mL) containing phosphatidylcholine, LPC, or fatty acid at various concentrations and cultured for 24 h under microaerobic conditions in the dark. After the culture, the cell suspension (1 mL) was centrifuged to remove the supernatant, and the cell pellets were resuspended in distilled saline (1 mL). Subsequently, the OD 660 nm of the cell suspension was measured using a spectrophotometer (Ultrospec; LKB Biochrom Ltd, Cambridge, UK). In addition, bacterial cell suspensions after cultivation for 24 h with phosphatidylcholine, LPC, or fatty acid were serially diluted 10-fold with a broth, spread on brain heart infusion agar (Difco Laboratories) plates containing 5% horse serum (Gibco, Auckland, NZ), and cultured for 1 week under microaerobic conditions. The CFU were calculated based on the colony counts and dilution factors.
Killing assay
The bacterial cells (approximately 10 7.5 CFU mL
À1
) were recovered from the dMbCD-free culture (10 mL) with or without FC (5 or 50 mg mL À1 ), E1 (15 mg mL À1 ), and TS (15 mg mL
) via centrifugation, washed once with distilled saline containing 0.2% dMbCD, resuspended in a dMbCDfree broth (10 mL) without steroids, and incubated with or without the phosphatidylcholine (100 mg mL
) at various time points under microaerobic conditions in the dark. After the incubation, the OD 660 nm or the CFU of the cell suspensions was determined using the methods described above.
Detection of flavodoxin in the culture supernatant
The bacterial cells were removed via filtration using a syringe filter (pore size: 0.45 mm) (25-mm GD/X Sterile Disposable Filter Device; Whatman Japan KK, Tokyo, Japan) to obtain the culture supernatant. The culture supernatants were subjected to anion-exchange chromatography using a Q-Sepharose column (Sigma-Aldrich Inc.) equilibrated with 50 mM Tris buffer (pH 7.5), and unnecessary components were washed out from the column with 50 mM Tris buffer (pH 7.5) containing 0.1 M NaCl. The proteins were subsequently eluted all at once from the column with 50 mM Tris buffer (pH 7.5) containing 0.3 M NaCl, concentrated with a centrifugal filter device (Centriprep YM-3; Millipore Co., Bedford, MA), collected by 80% methanol precipitation, electrophoresed with purified flavodoxin (Shimomura et al., 2007) using sodium dodecyl sulfate-12.5% polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970) , and stained with Coomassie brilliant blue (CBB).
Preparation of H. pylori with the absorbed steroid
The organisms were cultured for 24 h in a broth containing FC (5 or 50 mg mL À1 ), E1 (15 mg mL À1 ), or TS (15 mg mL
À1
) and washed once with distilled saline containing 0.2% dMbCD. The steroid absorption by the organisms was confirmed by detecting the CGs, E1, or TS in the membrane lipid compositions with a thin-layer chromatography (TLC) assay. In brief, the membrane lipids were extracted and purified according to the method of Folch et al., (1957) . After the cell pellets were washed three times in distilled saline and sonicated with chloroform-methanol (2 : 1), the insoluble materials in the solution were removed via centrifugation to obtain the supernatant. After adding a 0.2-fold volume of 0.9% KCl to the supernatant, the mixture was vigorously shaken and incubated at room temperature to separate the water phase from the chloroform phase. The chloroform phase was recovered and evaporated to obtain purified membrane lipids. The purified lipids were subjected to TLC with a solvent of chloroformmethanol-water (70 : 30 : 5), and the CGs, E1, or TS in the total lipids were detected using a solution of 60% sulfuric acid.
Membrane absorption assay of phosphatidylcholine, LPC, and fatty acid
The organisms were autoclaved for 15 min at 121 1C in distilled saline to prepare heat-killed cells. The heat-killed cells were suspended in a PPLO broth (1 mL) to adjust the cell number to approximately 10 9 CFU mL À1 , incubated overnight at 37 1C with phosphatidylcholine (100 mg mL À1 ), LPC (100 mg mL À1 ), or fatty acid (100 mg mL À1 ) in the presence or absence of 0.2% dMbCD in the dark, washed three times with distilled saline, and then recovered via centrifugation. The membrane lipids were extracted and purified from the recovered cells using the method of Folch and colleagues, developed on the silica gel plate with a solvent of chloroform-methanol-water (70 : 30 : 5) or chloroform-acetone (96 : 4), and analyzed using a solution of 60% sulfuric acid.
Separation of the outer and inner membranes
The outer and inner membranes of the H. pylori were purified according to the method described by Osborn et al. (1972) . In brief, cells cultured with FC (5 mg mL À1 ) or E1 (5 mg mL À1 ) were suspended in a cold 10 mM Tris buffer (pH 7.8) containing 0.75 M sucrose, and a twofold volume of 1.5 mM EDTA solution was slowly added to the cell suspension on ice. The cell suspension was subsequently treated with sonication on ice, and a fourfold volume of cold distilled water was slowly added in the sonicated cell lysates. Unnecessary components of the cell lysates were removed by centrifugation (1200 g) for 20 min at 4 1C to obtain spheroplasts in the supernatant. The spheroplasts were harvested by centrifugation (160 000 g) for 2 h at 4 1C, washed once with a cold 3.3 mM Tris buffer (pH 7.5) containing 1 mM EDTA and 0.25 M sucrose, and suspended in a cold 5 mM EDTA solution containing 25% sucrose.
Step gradients were prepared by layering 55%, 50%, 45%, 40%, 35%, and 30% sucrose solutions containing 5 mM EDTA (pH 7.5), and the spheroplast suspension was layered on top of the gradient and centrifuged (80 000 g) for 12 h at 4 1C. After sucrose density gradient centrifugation, the outer (higher specific gravity) and inner (lower specific gravity) membrane bands were collected via centrifugation (160 000 g) for 30 min at 4 1C and suspended in a 50 mM Tris buffer (pH 7.5).
The protein profiles in the outer and inner membranes were analyzed by SDS-PAGE. The FC, CGs, and E1 in both membranes were analyzed using a solution of 60% sulfuric acid after the TLC with a solvent of chloroformmethanol-water (70 : 30 : 5).
Peptide mass fingerprinting (PMF) analysis
After the SDS-PAGE of the outer membrane proteins, a protein band stained by a CBB was quarried out from the gel, digested with trypsin, and subjected to matrixassisted laser desorption ionization time-of-flight MS analysis (Shimadzu Co., Kyoto, Japan). The protein was identified by comparing the peptide masses obtained from the protein with the peptide masses of already-known proteins on a computer database using MASCOT Search (Matrix Science Ltd, London, UK).
Results
Phosphatidylcholine as the bactericidal agent against steroid-free H. pylori
First, we estimated the influence of phosphatidylcholines on the growth of H. pylori without a steroid by measuring the OD 660 nm in the cell suspensions. When the steroid-free H. pylori were cultured with each phosphatidylcholine in a 0.2% dMbCD-PPLO broth, the OD 660 nm values of the cell suspensions cultured with PC-3 or PC-4 (two of the four phosphatidylcholines investigated) were somewhat lower than the baseline OD 660 nm (lane i) of the cell suspension before the culture (Fig. 1b) . In contrast, the OD 660 nm values of the cell suspensions cultured with PC-1 or PC-2 increased to levels comparable to the OD 660 nm in the control cell suspension cultured without phosphatidylcholines. Thus, the growth of the steroid-free H. pylori was unaffected by the presence of PC-1 or PC-2, but was abolished by the presence of PC-3 or PC-4. These results indicate that PC-3 and PC-4 inhibit the growth of the steroid-free H. pylori by some means or another. LPC and unsaturated fatty acids such as linoleic acid (C 18:2 ) and arachidonic acid (C 20:4 ) kill various bacteria and fungi. Considering this, we examined the bactericidal action of C 18:2 , C 20:4 , and LPC, three constituents of the PC-3 and PC-4, against the steroid-free H. pylori. When the steroid-free H. pylori were cultured with one of the unsaturated fatty acids or LPC in a 0.2% dMbCD-PPLO broth, surprisingly, the presence of C 18:2 , C 20:4 , or LPC increased the OD 660 nm values in the cell suspensions to levels comparable with the OD 660 nm of the control suspension (Fig. 1b) . Thus, C 18:2 , C 20:4 , and LPC did not exhibit bactericidal action against the steroid-free H. pylori even when added in combination. These results indicate that the bactericidal activity of C 18:2 , C 20:4 , and LPC conferred via the hydrolysis of PC-3 and PC-4 is not involved in the inhibitory effects of the two phosphatidylcholines on the growth of the steroid-free H. pylori. Thus, our next challenge was to determine why the H. pylori was unaffected by the bactericidal actions of C 18:2 , C 20:4 , and LPC. To resolve this question, we examined the effect of dMbCD on the bactericidal actions of C 18:2 , C 20:4 , and LPC. First, we analyzed the membrane absorption of phosphatidylcholines and unsaturated fatty acids in the presence or absence of dMbCD using heat-killed steroidfree H. pylori cells. When the heat-killed steroid-free cells were incubated with PC-3 or PC-4 for TLC analysis, the spots of the two phosphatidylcholines detected in the membrane lipid compositions of the cells incubated with 0.2% dMbCD had much higher densities than the spots of the phosphatidylcholines detected in the membrane lipid compositions of the cells incubated without dMbCD (Fig. 2a) . These results indicate that dMbCD has the potential to promote the absorption of PC-3 and PC-4 into the H. pylori cell surface. When the heat-killed steroid-free cells were incubated with C 18:2 or C 20:4 in the absence of dMbCD, the spots of the two unsaturated fatty acids were detected at extremely high densities in the membrane lipids of the cells (Fig. 2a) . Yet, when the heat-killed steroid-free cells were incubated with C 18:2 or C 20:4 in a 0.2% dMbCD medium, the spot densities of the two unsaturated fatty acids detected in the membrane lipids were much lower than Fig. 2 . Absorption of phosphatidylcholines and fatty acids into the heat-killed steroid-free Helicobacter pylori cells in the presence or absence of dMbCD, and the bactericidal activity of the phosphatidylcholines, LPC, and fatty acids against steroid-free H. pylori in the presence or absence of dMbCD. (a) The heat-killed cells of the steroid-free H. pylori strain NCTC 11638 (10 9 CFU mL À1 ) were incubated overnight at 37 1C with or without PC-3, PC-4, C 18:2 , and C 20:4 at a 100 mg mL À1 concentration in the presence or absence of 0.2% dMbCD. After the incubation, the membrane lipids of the heat-killed cells (the cell number of 10 9 ) were purified using the Folch method, subjected to TLC analysis with a solvent of chloroform-methanol-water (70 : 30 : 5) for phosphatidylcholines or chloroform-acetone (96 : 4) for fatty acids, and detected using 60% sulfuric acid solution. PE, phosphatidylethanolamine; PG-CL, phosphatidylglycerol-cardiolipin. The results shown are representative of the findings obtained from two independent experiments. (b) The steroid-free H. pylori strain NCTC 11638 (10 5.5 CFU mL
À1
) was cultured for 24 h with phosphatidylcholines, LPC, and fatty acids at the indicated concentrations in the presence or absence of 0.2% dMbCD. After the cultures, the CFU were determined. The closed and opened symbols indicate the CFU in the presence and absence of dMbCD, respectively. The results are shown as the mean CFU AE SD obtained from three independent experiments. the spot densities of the fatty acids in the membrane lipids of the cells without dMbCD. These results indicate that dMbCD has the potential to prevent the absorption of C 18:2 and C 20:4 into the H. pylori cell surface. Incidentally, LPC was undetectable in the membrane lipid compositions of the heat-killed steroid-free cells incubated with the LPC, regardless of the presence or absence of dMbCD (data not shown). LPC carries hydroxyl and phosphate groups, which confer hydrophilicity, and a saturated fatty acid (C 16:0 ), which confers hydrophobicity (Fig. 1a) . LPC is, therefore, an amphipathic compound, and the LPC absorbed into the heat-killed cells appeared to be released from the cell surface during the washing procedure.
Next, we estimated the growth of the steroid-free H. pylori cultured with the phosphatidylcholines in the presence or absence of dMbCD by determining the CFU in the cell suspensions. The addition of PC-3 and PC-4 at the respective concentrations of 10 and 100 mg mL À1 remarkably inhibited the growth of the steroid-free H. pylori, and each suspension had a lower CFU than the initial CFU (approximately 10 5.5 CFU mL À1 ) before the culture (Fig. 2b) . Thus, the actions of PC-3 and PC-4 were found to be bactericidal against the steroid-free H. pylori. Moreover, the presence of dMbCD (0.2%) had no effect on the bactericidal actions of the two phosphatidylcholines, and the steroid-free H. pylori cultured with PC-3 or PC-4 were killed in a manner similar to those cultured in the absence of dMbCD. In contrast, PC-1 and PC-2 had no influence on the growth of the steroidfree H. pylori in the presence or absence of 0.2% dMbCD, and the CFU of each suspension was comparable with the control CFU without phosphatidylcholines, even when PC-1 and PC-2 were added at a 100 mg mL À1 concentration. Next, we examined the bactericidal ability of LPC and fatty acids against the steroid-free H. pylori in the presence or absence of dMbCD. In the presence of dMbCD, the LPC and fatty acids exhibited no bactericidal action against the steroidfree H. pylori. Thus, when the steroid-free H. pylori (approximately 10 5.5 CFU mL À1 ) were cultured with LPC, C 18:2 , C 20:4, or palmitic acid (C 16:0 ) at concentrations ranging from 0.1 to 10 mg mL À1 , the CFU were all comparable with the control CFU without LPC and fatty acids (Fig. 2b ). Yet, in the absence of dMbCD, LPC exhibited a strong bactericidal action against the steroid-free H. pylori, and the CFU were below the limits of detection when the organisms (approximately 10 5.5 CFU mL À1 ) were cultured with the LPC at the 10 mg mL À1 concentration. Similarly, C 18:2 and C 20:4 also exhibited strong bactericidal actions against the steroid-free H. pylori, and the CFU were below the limits of detection when each unsaturated fatty acid was added at a 1 mg mL
concentration. In contrast, C 16:0 exhibited no bactericidal action against any of the organisms, even those cultured in the absence of dMbCD. These results, together with the results of the membrane absorption assay (Fig. 2a) , indicate that PC-3 and PC-4 have the potential to kill the steroid-free H. pylori, and that the killing abilities of PC-3 and PC-4 are maintained even in the presence of dMbCD, whereas dMbCD counteracts the killing abilities of the LPC and unsaturated fatty acids by preventing the absorption of these compounds into the H. pylori cell surfaces.
In our next experiments, we went on to elucidate the bactericidal mechanisms of PC-3 and PC-4. When the steroid-free H. pylori cell suspension was incubated with PC-3 or PC-4, the addition of the phosphatidylcholines reduced the OD 660 nm of the cell suspension to below the half of the OD 660 nm in the control cell suspension without phosphatidylcholines. These results suggest that the bactericidal actions of PC-3 and PC-4 are attributable to a lytic activity against the steroid-free H. pylori.
To confirm the lytic activity of PC-3 and PC-4, we attempted to detect flavodoxin (FldA), a representative intracellular protein (Hughes et al., 1995; Freigang et al., 2002; Shimomura et al., 2007) , in the culture supernatants. In the SDS-PAGE analysis, the culture supernatant obtained from the steroid-free H. pylori incubated without phosphatidylcholines only contained negligible levels of the FldA protein (Fig. 3b) . In contrast, the FldA protein was strongly ) were incubated for 8 h with or without PC-3 (100 mg mL
) and PC-4 (100 mg mL À1 ) in the medium. After the incubation, the proteins extracted from the culture supernatants were subjected to SDS-PAGE analysis and stained using CBB. Lane 1 is a purified FldA (1 mg per lane). Lane 2 shows the protein profile in the culture supernatant (3 mL) of the phosphatidylcholine-untreated cells. Lanes 3 and 4 show the protein profiles in the culture supernatants (3 mL) of the cells treated with PC-3 and PC-4, respectively. The results shown are representative of the findings obtained from two independent experiments. detected in the steroid-free H. pylori incubated with PC-3 or PC-4. We thus found that FldA, a typical intracellular protein, spilled into the culture supernatant from the cells treated with PC-3 and PC-4. These results, together with our findings on the OD 660 nm alterations (Fig. 3a) , indicate that PC-3 and PC-4 promote a collapse of the membrane structures in the steroid-free H. pylori via an increase in the membrane permeability.
Phosphatidylcholine resistance of H. pylori by absorbed steroids
The above experiments were all carried out using a steroidfree medium. Therefore, H. pylori could not naturally use steroid as a membrane lipid component. Next, we prepared H. pylori with absorbed FC, a typical steroid compound, in the form of CGs. To confirm the production of the CGs, we analyzed the membrane lipid compositions of the H. pylori from this culture. The TLC analysis detected all three CG variants (CGL, CAG, and CPG) in the lipid compositions of the H. pylori with assimilated FC (Fig. 4a) . In contrast, the CGs were not detectable in the lipid compositions of H. pylori cultured without FC. These results indicate that H. pylori absorbs the FC when its steroid is added in the medium, and retains the FC via glucosylation of its steroid in the membrane.
Next, we estimated the bactericidal effects of PC-3 and PC-4 against the H. pylori with the absorbed FC. When the steroid-free H. pylori strain NCTC 11638 was incubated with PC-3 or PC-4, the phosphatidylcholine killed the steroidfree cells in a time-dependent manner, resulting in a progressive decrease of the CFU during the incubation (Fig. 4b) . In contrast, the organisms with absorbed FC were not affected by the bactericidal actions of PC-3 and PC-4, and the alterations of CFU levels in the presence of PC-3 and PC-4 roughly corresponded to those of the control CFU ) were incubated for 12 h in the presence or absence of PC-3 (100 mg mL À1 ) in the steroid-free medium, and thereafter, the CFU were determined. FC-absorbed (FC1) and steroid-free (S À ) H. pylori A-19 strains (each 10 7.5 CFU mL
À1
) were incubated for 24 h in the presence or absence of PC-3 (100 mg mL
) in the steroid-free medium, and thereafter, the CFU were determined. The left and right graphs plot the results for the ATCC 43504 and A-19 strains, respectively. The results are shown as the mean CFU AE SD obtained from three independent experiments. levels in the absence of the two phosphatidylcholines. Thus, the H. pylori strain NCTC 11638, which had absorbed and glucosylated the FC, resisted the bactericidal actions of PC-3 and PC-4.
Next, we estimated the bactericidal ability of PC-3 against the other H. pylori strains. When the steroid-free H. pylori strains ATCC 43504 and A-19 were incubated with PC-3, both strains succumbed to the bactericidal action of PC-3 and exhibited a remarkable decline in CFU vs. the control CFU without PC-3 (Fig. 4c) . In contrast, the FC-absorbed strains ATCC 43504 and A-19 resisted the bactericidal action of PC-3 and exhibited CFU comparable with the control CFU without PC-3. Thus, all of the H. pylori strains investigated acquired resistance against the bacteriolytic action of the PC-3 by assimilating the exogenous FC in the form of CGs in the membrane.
As described above, H. pylori retains FC in the form of glucosyl-FCs (CGs). This raises the question as to whether the CGs are more important rather than the FC itself in the expression of phosphatidylcholine resistance in H. pylori. To resolve this question, we examined the phosphatidylcholine resistance in organisms with another absorbed steroid. Our recent study has shown that H. pylori effectively absorbs and retains the female hormone E1, but fails to glucosylate estrogen (Hosoda et al., 2009 ). In addition, we have found that the male hormone TS is hardly absorbed into H. pylori membranes. Therefore, we decided to use E1 and TS as steroid tools that are not glucosylated by H. pylori. When H. pylori strain NCTC 11638 or ATCC 43504 was cultured with E1, a spot of E1, the estrogen identified with the authentic E1 in the TLC analysis was detected in the membrane lipid compositions of each H. pylori strain (Fig. 5a) . In contrast to E1, TS spot was undetectable in the membrane lipids of H. pylori in the TLC analysis, and the lipid profiles of the organisms cultured with TS were identical to the lipid profiles of the organisms cultured without the steroid shown in Fig. 4a . These results indicate that H. pylori utilizes E1 as a membrane lipid component without glucosylating it, whereas H. pylori fails to absorb the TS into the membranes.
Based on the results of the above mentioned steroid hormone absorption, we estimated the bactericidal activity of PC-3 and PC-4 against H. pylori with absorbed E1. As shown in Fig. 5b , the two H. pylori strains (NCTC 11638 and ATCC 43504) treated with TS succumbed to the bactericidal action of PC-3 and PC-4 as well as the organisms untreated with steroid (see Fig. 4 ), and exhibited a remarkable decline in CFU vs. the control CFU without the phosphatidylcholines. In contrast, both strains with absorbed E1 were negligibly affected by the bactericidal action of PC-3 and PC-4, and retained higher levels of CFU than the TS-treated strains with the phosphatidylcholines, although the CFU levels of the E1-absorbed organisms with ) were incubated for 24 h (strain NCTC 11638) or 12 h (strain ATCC 43504) in the presence or absence of PC-3 (100 mg mL
) and PC-4 (100 mg mL À1 ) in the steroid-free medium. After the incubation, the CFU were determined. The upper and lower graphs plot the results for the NCTC 11638 and ATCC 43504 strains, respectively. The results are shown as the mean CFU AE SD obtained from three independent experiments. the phosphatidylcholines were somewhat lower than the control CFU levels of the E1-absorbed organisms without the phosphatidylcholines. Thus, H. pylori expressed phosphatidylcholine resistance even when absorbed E1 without glucosylating it. These results, together with our findings on the FC absorption in H. pylori (Fig. 4) , indicate that bacteria of this species acquire a resistance against the bacteriolytic activity of PC-3 and PC-4 by absorbing the exogenous steroids into the membranes.
Localization of the steroids assimilated by H. pylori
To examine the localization of the steroids absorbed by H. pylori, we attempted to separate the outer and inner membranes of the bacterial cells. In the SDS-PAGE analysis of the outer and inner membrane proteins, a protein with a molecular weight of about 20 kDa was detected in large quantities in the outer membrane fraction (data not shown). PMF analysis identified a 20-kDa protein with a lipoprotein (Lpp20) matching the Lpp20 protein of the H. pylori strain J99, with a top score of 78 in the Mascot Search. Given that Lpp20 is a representative outer membrane protein (Keenan et al., 2000) , and further, that the level of Lpp20 detected was clearly higher in the outer membrane fraction than in the inner membrane fraction, we could assume that the two membranes were separated successfully. Based on the results of the above SDS-PAGE and PMS analyses, we examined the localization of the steroids in both the outer and the inner membranes. When the H. pylori (strain NCTC 11638) was cultured with FC for the TLC analysis of the membrane lipid compositions, the spot of FC itself absorbed was detected at a similar density in both the outer and the inner membrane fractions (Fig. 6a) . In contrast, the glucosyl-FCs (CGs) produced via the absorption of FC were detected at clearly higher levels in the outer membrane fraction than in the inner membrane fraction. As with the FC, the spot of E1 absorbed by the H. pylori was also detected at a similar density in both the outer and the inner membrane fractions in the TLC analysis (Fig. 6b ). These results indicate that H. pylori absorbs exogenous steroids into the outer and inner membranes and utilizes the glucosylated steroids as major lipid components constituting the outer membrane.
Discussion
A recent study has demonstrated that CGs play an important role in evading the immunoresponses of the hosts; H. pylori manifesting CGs resists phagocytosis in macrophages, does not stimulate the activation of antigen-specific T cells, and colonizes mouse gastric epithelium, whereas H. pylori treated with excessive FC or the HP0421 gene-knockout H. pylori that cannot glucosylate FC succumbs to phagocytosis in macrophages, induces the activation of antigenspecific T-cells, and is promptly excluded from mouse gastric epithelium . In this study, we showed that H. pylori expresses phosphatidylcholine resistance even when E1 was absorbed and retained without glucosylating it. Thus, this result indicates that the glucosylation of steroid is so far not important in conferring resistance to the bactericidal action of PC-3 and PC-4 upon H. pylori, although the glucosylation of steroid is essential for H. pylori to evade the host immune system. Our recent study has demonstrated that H. pylori selectively absorbs 3b-OH and 3-OH steroid hormones, and specifically glucosylates only steroid hormones possessing 3b-OH independent of the other functional groups by modifying the steroid framework (Hosoda et al., 2009) . Thus, in the case of H. pylori with absorbed 3b-OH steroids, the 3b-OH conformation in the steroids may play an important role in the pathogen recognition of the immune-competent cells. Therefore, H. pylori may need to mask the 3b-OH of the steroids with a glucose molecule in evading the immunoresponses of these cells. Further investigations will be necessary to clarify the physiological significance of steroid glucosylation in H. pylori.
dMbCD is a cyclic oligomer of glucose consisting of seven D-glucopyranose units linked by a-glucosidic bonds and has the ability to solubilize lipids through the formation of molecular inclusion complexes (Ohtani et al., 1989) . Although the detailed mechanism of the interaction of dMbCD with fatty acid has not been well understood, a few investigations speculated that dMbCD adsorbs unsaturated fatty acids that exhibit toxicity to microorganisms, and thereby scavenges those fatty acids in the media to support the growth of microorganisms (Olivieri et al., 1993; Marchini et al., 1995) . In this study, we found that dMbCD prevents the absorption of the unsaturated fatty acids (C 18:2 and C 20:4 ) into the H. pylori cell surface, but promotes the absorption of the phosphatidylcholines (PC-3 and PC-4) into the cell surface. Given that dMbCD has a detergent function, we can assume that dMbCD counteracts the hydrophobic interactions among fatty acids and bacterial membranes by solubilizing the fatty acids. We could not, however, clarify as to why dMbCD promotes the absorption of the phosphatidylcholines into the H. pylori membranes. Perhaps, our finding may be a novel function of dMbCD. Further investigations will therefore be necessary to elucidate the interaction of dMbCD with phosphatidylcholine and H. pylori membranes.
In the TLC analysis for the lipid compositions of the outer and inner membranes, the steroids (FC and E1) absorbed by H. pylori existed in both the outer and the inner membranes, while the CGs synthesized via the FC absorption were localized in the outer membrane rather than in the inner membrane. This finding led us to consider a membrane transport system for the steroids in the organisms. Thus, the steroids absorbed by H. pylori appear to be shifted from the outer membrane to the inner membrane, and thereafter, the steroids glucosylated in the inner membrane appear to be transported to the outer membrane. It remains to be clarified, however, whether H. pylori has a membrane transport system for the steroids. In addition, the membrane localization of cholesterol a-glucosyltransferase (HP0421) that catalyzes the CG synthesis has still not been identified. Investigations into the proteins involved in the steroid transport are, therefore, required to elucidate the detailed mechanisms of the steroid absorption and to identify the location where the steroids are glucosylated.
Phosphatidylcholine is not a single molecule, but a family of variants with different fatty acid compositions attached to the glycerol backbone of the phosphatidylcholine. The predominant phosphatidylcholine in human serum has been known to carry a palmitic acid (C 16:0 ) molecule and a linoleic acid (C 18:2 ) molecule (Nakamura, 1997) , and more recently, the predominant phosphatidylcholine in the human gastric mucus has also been shown to carry the same two fatty acids (Orihara et al., 2001) . Thus, PC-3 is the most prevalent phosphatidylcholine in humans. Helicobacter pylori colonizes the human gastric epithelium and inhabits the human stomach for many years. On this basis, we can speculate that H. pylori is constantly exposed to various phosphatidylcholine variants, particularly PC-3. A number of studies have indicated that the sex hormones estrogens and androgens exist in the human stomach environment (Takeyama et al., 2000; Javitt et al., 2001; Turgeon et al., 2001; Matsuyama et al., 2002; Miki et al., 2002; Takano et al., 2002; Kominea et al., 2004) : the enzymes involved in the biosynthesis and activation of sex hormones are expressed in the human stomach tissue, and the expression of sex hormone receptors is found in gastric cancer. Thus, it is highly possible that H. pylori assimilates various steroids as the membrane lipid components in human stomach tissues. Our results from this study demonstrated that phosphatidylcholine carrying linoleic acid or arachidonic acid kills H. pylori that has failed to absorb steroids, while the H. pylori that has absorbed steroids resist the bactericidal actions of the same phosphatidylcholines. We also found that H. pylori retains the steroids in both the outer and the inner membranes. These results indicate that the steroid absorption into H. pylori plays an important role in reinforcing the membrane lipid barrier and conferring resistance to the bacteriolytic action of hydrophobic compounds such as phosphatidylcholine.
